Amgen 2002 Annual Report Download - page 47

Download and view the complete annual report

Please find page 47 of the 2002 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 72

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72

AMGEN 2002 ANNUAL REPORT
Consolidated Statements of Stockholders’ Equity
(In millions)
(Accumulated Accumulated
Common stock deficit)/ other
Number and additional retained comprehensive
Years ended December 31, 2002, 2001, and 2000 of shares paid-in capital earnings income (loss) Total
Balance at December 31, 1999 1,017.9 $ 2,072.3 $ 966.0 $(14.8) $ 3,023.5
Comprehensive income:
Net income — — 1,138.5 — 1,138.5
Other comprehensive income, net of tax:
Unrealized gains on securities,
net of reclassification adjustments — — — 99.0 99.0
Foreign currency translation adjustments — — — (21.6) (21.6)
Total other comprehensive income ————77.4
Comprehensive income ————1,215.9
Issuance of common stock upon the exercise of
employee stock options and in connection
with an employee stock purchase plan 29.1 333.7 — — 333.7
Tax benefits related to employee stock options — 376.6 — — 376.6
Issuance of common stock for the acquisition
of Kinetix Pharmaceuticals, Inc 2.6 164.7 — — 164.7
Repurchases of common stock (12.2) — (799.9) — (799.9)
Balance at December 31, 2000 1,037.4 2,947.3 1,304.6 62.6 4,314.5
Comprehensive income:
Net income — — 1,119.7 — 1,119.7
Other comprehensive loss, net of tax:
Unrealized losses on securities,
net of reclassification adjustments — — — (6.7) (6.7)
Foreign currency translation adjustments — — — 0.4 0.4
Total other comprehensive loss ————(6.3)
Comprehensive income ————1,113.4
Issuance of common stock upon the exercise of
employee stock options and in connection
with an employee stock purchase plan 21.1 282.3 — — 282.3
Tax benefits related to employee stock options — 244.5 — — 244.5
Repurchases of common stock (12.7) — (737.5) — (737.5)
Balance at December 31, 2001 1,045.8 3,474.1 1,686.8 56.3 5,217.2
Comprehensive loss:
Net loss — — (1,391.9) — (1,391.9)
Other comprehensive income, net of tax:
Unrealized losses on securities,
net of reclassification adjustments — — — (17.3) (17.3)
Foreign currency translation adjustments — — — 28.2 28.2
Total other comprehensive income ————10.9
Comprehensive loss ————(1,381.0)
Issuance of common stock for the acquisition
of Immunex Corporation 244.6 14,313.0 — — 14,313.0
Fair value of options assumed from Immunex — 870.2 — — 870.2
Issuance of common stock upon the exercise of
employee stock options and in connection
with an employee stock purchase plan 26.7 435.4 — — 435.4
Tax benefits related to employee stock options — 251.6 — — 251.6
Repurchases of common stock (28.0) — (1,420.4) — (1,420.4)
Balance at December 31, 2002 1,289.1 $19,344.3 $(1,125.5) $ 67.2 $18,286.0
See accompanying notes.
Page 45